Brief: Xspray Pharma Updates On Dasynoc And Nilopki Status
02/10/2026 07:05
BRIEF-Xspray Pharma Updates On Dasynoc And Nilopki Status Oct 2 (Reuters) - Xspray Pharma publ AB XSPRAY.ST:
PROVIDES REGULATORY STATUS UPDATE FOR DASYNOC AND NILOPKI
REITERATES PLAN TO RESUBMIT NEW DRUG APPLICATIONS FOR BOTH PRODUCT CANDIDATES TO FDA, IN Q4 OF 2026
Source text: ID:nMFN805n6J
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))